Replimune Group, Inc. REPL
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 81.49M | 86.01M | 99.62M | 103.96M | 103.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 268.39M | 296.26M | 318.32M | 324.22M | 318.34M |
| Operating Income | -268.39M | -296.26M | -318.32M | -324.22M | -318.34M |
| Income Before Tax | -271.59M | -297.56M | -314.49M | -315.27M | -309.80M |
| Income Tax Expenses | -551.00K | -551.00K | -551.00K | -418.00K | 468.00K |
| Earnings from Continuing Operations | -271.03 | -297.01 | -313.94 | -314.85 | -310.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -271.03M | -297.01M | -313.94M | -314.85M | -310.26M |
| EBIT | -268.39M | -296.26M | -318.32M | -324.22M | -318.34M |
| EBITDA | -262.64M | -290.44M | -312.56M | -318.88M | -312.95M |
| EPS Basic | -2.80 | -3.16 | -3.39 | -3.44 | -3.46 |
| Normalized Basic EPS | -1.75 | -1.98 | -2.12 | -2.15 | -2.16 |
| EPS Diluted | -2.80 | -3.16 | -3.39 | -3.44 | -3.46 |
| Normalized Diluted EPS | -1.75 | -1.98 | -2.12 | -2.15 | -2.16 |
| Average Basic Shares Outstanding | 389.82M | 376.56M | 371.21M | 366.54M | 357.85M |
| Average Diluted Shares Outstanding | 389.82M | 376.56M | 371.21M | 366.54M | 357.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |